Sanofi SA

SAN.PA · Health Technology · Pharmaceuticals: Major · FR

99,412 employees · sanofi.com

About

Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide.

Annual results

Reported figures, EUR · revenue up 5.5% in 2025

YearRevenueNet incomeNet marginFree cash flow
202546.7B7.8B16.7%—
202444.3B5.6B12.6%—
202341.1B5.4B13.1%—
202240.3B8.4B20.8%—
202139.2B6.2B15.9%—

Dividends per share

2026 4.12 EUR2025 3.92 EUR2024 3.76 EUR2023 3.56 EUR2022 3.31 EUR

SAN.PA in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Sanofi SA are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Sanofi SA (SAN.PA) — company profile and financials · MarketPulse